Dr. Shalini Bansil, MD

Dr. Bansil practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Dr. Bansil's NPI, 1467429340, was assigned on March 1, 2006. Dr. Bansil holds District of Columbia license MD044603.

Dr. Bansil's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Dr. Bansil's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dr. Bansil is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Bansil to 1 more hospital and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bansil practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bansil's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bansil is licensed in District of Columbia.

CMS data shows 76 Medicare services from Dr. Bansil across 3 procedure codes in 2024, for 46 Medicare patients. Medicare paid $4,828 for them. Every service was in an office.

CMS counts 46 Medicare patients who saw Dr. Bansil in 2024. The largest group is under 65, with 31 patients. 59% of them have high blood pressure, and 52% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bansil's median patient age at 54, with 66% women.

In 2024, Dr. Bansil wrote 942 Medicare Part D claims for 108 patients. 89% of them were for generic drugs. CMS names the drug for 802 of them, across 23 drugs with 11 or more claims each, at $843,796 in total drug cost. In 2023, CMS named 262 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bansil for performance year 2024, reported through an alternative payment model (APM). Dr. Bansil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bansil as offering telehealth.

CMS Open Payments shows 32 general payments to Dr. Bansil from 9 drug and device companies from 2016 to 2017. Speaker and faculty fees make up the largest share, 81% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $2,077.